Literature DB >> 34233400

Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience.

Fatma Aydın1, Tuba Kurt1, Müge Sezer1, Nilüfer Tekgöz1, Zahide Ekici Tekin1, Saliha Kanık Yüksek2, Banu Çelikel Acar1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34233400     DOI： 10.1111/ijcp.14030

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN： 1368-5031            Impact factor:   2.503


× No keyword cloud information.
  2 in total

1.  Robust neutralising antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood onset rheumatic diseases.

Authors:  Joo Guan Yeo; Wan Ni Chia; Kai Liang Teh; Yun Xin Book; Sook Fun Hoh; Xiaocong Gao; Lena Das; Jinyan Zhang; Nursyuhadah Sutamam; Amanda Jin Mei Lim; Su Li Poh; Shi Huan Tay; Katherine Nay Yaung; Xin Mei Ong; Sharifah Nur Hazirah; Camillus Jian Hui Chua; Jing Yao Leong; Lin-Fa Wang; Salvatore Albani; Thaschawee Arkachaisri
Journal:  Rheumatology (Oxford)       Date:  2022-02-23       Impact factor: 7.580

2.  The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study.

Authors:  Betul Sozeri; Kadir Ulu; Ummusen Kaya-Akça; Fatih Haslak; Aysenur Pac-Kisaarslan; Gulcin Otar-Yener; Ozge Baba; Ozge Altug-Gucenmez; Nihal Sahin; Esra Bağlan; Hafize Emine Sönmez; Figen Cakmak; Kubra Ozturk; Deniz Gezgin-Yıldırım; Seher Şener; Kenan Barut; Ezgi Deniz Batu; Mehmet Yıldız; Ozge Basaran; Amra Adrovic; Sezgin Sahin; Semanur Ozdel; Yelda Bilginer; Muammer Hakan Poyrazoglu; Ferhat Demir; Selcuk Yuksel; Mukaddes Kalyoncu; Ozgur Kasapcopur; Seza Ozen; Nuray Aktay-Ayaz
Journal:  Rheumatol Int       Date:  2021-09-27       Impact factor: 2.631
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.